#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epilepsy Arginase deficiency Endometrial cancer recurrent Systemic sclerosis pulmonary Keratosis follicular Oesophageal adenocarcinoma stage II Haemophilia B with anti factor IX Pancreatic neuroendocrine tumour Infective uveitis Metastatic malignant melanoma Multifocal motor neuropathy Congenital cystic kidney disease Hepatoblastoma Anti-glomerular basement membrane disease Systemic candida More trials…

    Learn about Rare Diseases

    Advanced systemic mastocytosis – Diagnostics Fragile X syndrome – Treatment Nephroblastoma – Trials in Disease Osteosarcoma recurrent – Treatment VEXAS syndrome – Treatment Ehlers-Danlos syndrome – Life with Disease Rosai-Dorfman syndrome – Treatment KBG syndrome SAPHO syndrome – Life with Disease Synovial sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    DICLOFENAC POTASSIUM Ima203Cd8 Gebasaxturev ALG-000184 Allopurinol Sodium Mometasone Furoate Sorafenib Tosilate Inclisiran Zilovertamab Vedotin Stx-241 Eo2317 Azelastine Hydrochloride Lorundrostat Ucart20X22 AZD5148 Foscarnet Sodium Hexahydrate Flutamide Favezelimab Cinchocaine Hydrochloride Corylus Avellana L. More therapies…

    Learn about Your Condition

    Renal disorder Notalgia paraesthetica Brain injury Inflammatory bowel disease Vascular malformation Erythema migrans Liver disorder Hepatobiliary disease Atrial septal defect Squamous cell carcinoma Medulloblastoma recurrent Aortic valve disease Malignant melanoma Multiple sclerosis Hip fracture More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Bulgaria Italy Poland Spain

  • Study on Insulin Aspart, Salbutamol, and Glucose for Treating Acute Hyperkalemia in Emergency Department Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperkalaemia
    Investigated Drugs:
    • Insulin Aspart
    • Insulin Lispro
    • Salbutamol
    France

  • Study on the Safety and Initial Effects of AAV9-CAG-coh-SGSH in Children with Sanfilippo A Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Mucopolysaccharidosis III
    Investigated Drugs:
    • Adeno-Associated Viral Vector Serotype 9 Containing The Human Sulfamidase Gene
    Spain

  • Study on the Safety and Effectiveness of Utreglutide (GL0034) for Adults with Type 2 Diabetes Not Well Managed with Metformin or Lifestyle Changes

    Not recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Utreglutide
    Germany

  • Long-Term Safety and Efficacy Study of Nedosiran Injection for Patients with Primary Hyperoxaluria

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperoxaluria
    Investigated Drugs:
    • Nedosiran
    France Germany Italy The Netherlands Norway Spain

  • Study on Efinopegdutide for Adults with Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Efinopegdutide
    France Spain
Previous Page
1 … 40 41 42 43 44 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!